In a report released today, James Orsborne from Stifel Nicolaus maintained a Hold rating on Haleon PLC (HLN – Research Report), with a price target of p370.00.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
James Orsborne’s rating is based on Haleon PLC’s solid performance and strong fundamentals, which position it as a quality stock in the consumer healthcare sector. Despite these strengths, the stock is currently trading at a premium compared to its peers, limiting the potential for further upside unless there is a significant increase in growth.
Orsborne anticipates that Haleon will meet its 2024 expectations, but notes that the company’s growth projections for 2025 are at the lower end of consensus estimates. The current valuation appears justified only if Haleon can achieve growth at the higher end of its guidance range. Consequently, Orsborne maintains a Hold rating, suggesting investors wait for a clearer growth trajectory or a more favorable entry point.
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue